Platform for Biomarkers
The Platform for Biomarkers offers three complementary immunoassay technologies to enable highly sensitive, multiplexed and robust detection of protein biomarkers across a wide dynamic range:
TECHNOLOGIES / CAPABILITIES
Each technology provides unique analytical capabilities, allowing users to tailor detection strategies according to the required sensitivity, sample volume, dynamic range, and number of analytes.
PERSONNEL
Head of Platform
Scientific Coordinator
SELECTED PUBLICATIONS OF THE PLATFORM
- Hexaraphane as a potential therapeutic strategy for tauopathies Redox Biology, 2026. DOI: 10.1016/j.redox.2026.104107
- Influence of Lifestyle on Brain Sensitivity to Circulating Insulin-like Growth Factor 1 Mol Sci, 2025. DOI: 10.3390/ijms262010008.
- Stepwise approach to alzheimer’s disease diagnosis in primary care using cognitive screening, risk factors, neuroimaging and plasma biomarkers Scientific Reports, 2025. DOI: 10.1038/s41598-025-17394-3
- Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer’s Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms International Journal of Molecular Sciences, 2024. DOI: 10.3390/ijms25094594
- Serum assessment of traumatic axonal injury: the correlation of GFAP, t-Tau, UCH-L1, and NfL levels with diffusion tensor imaging metrics and its prognosis utility J Neurosurg, 2023. DOI: 10.3171/2022.5.JNS22638
- New, Fully Implantable Device for Selective Clearance of CSF-Target Molecules: Proof of Concept in a Murine Model of Alzheimer’s Disease International Journal of Molecular Sciences, 2022. DOI: 10.3390/ijms23169256
- Linking Plasma Amyloid Beta and Neurofilament Light Chain to Intracortical Myelin Content in Cognitively Normal Older Adults Frontiers in Aging Neuroscience, 2022. DOI: 10.3389/fnagi.2022.896848
- Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers Parkinsonism Relat Disord, 2022. DOI: 10.1016/j.parkreldis.2022.01.024
- Whole Blood Expression Pattern of Inflammation and Redox Genes in Mild Alzheimer’s Disease Journal of Inflammation Research, 2021. DOI: 10.2147/JIR.S334337